Assignee's Change of Address

Recorded: 2025-11-13 Pages: 2

Assignor

CHEMOCENTRYX, INC.

Executed: 2023-06-23

Assignee

CHEMOCENTRYX, INC.

ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CALIFORNIA, 91320-1799

Covered Property (1)

Compositions and Methods for Treating Inflammatory Bowel Disease Using CCR9 Inhibitor and Anti-Il-23 Blocking Antibodies

Application: 18/531,086 →

Publication: US 2024/0100041

Related Assignments (1)

Other recorded transfers of the patent in this record — the chain of ownership.